Ligamentum flavum hypertrophy is the thickening and stiffening of the ligamentum flavum — the elastic ligament lining the rear wall of the spinal canal. Caused by aging, disc degeneration, and chronic mechanical stress, it narrows the canal, compresses nerve roots, and produces the defining symptoms of lumbar spinal stenosis.

  • LFH is a leading structural cause of spinal stenosis in adults over 50.
  • Symptoms are positional — worse with standing and walking, better with sitting or bending forward.
  • Conservative care is the standard first step for mild to moderate cases.
  • When underlying disc pathology drives the problem, addressing the disc is a clinically relevant option.
  • A clinical evaluation is the only way to know which approach fits your anatomy and symptoms.

What Is the Ligamentum Flavum?

The ligamentum flavum (Latin for “yellow ligament”) runs along the posterior wall of the spinal canal, connecting adjacent vertebral laminae from the cervical spine through the lumbar region. In a healthy spine it is thin and elastic — typically 2–4 mm thick in the lumbar spine — stretching when you bend forward and recoiling when you stand upright.

Hypertrophy means the ligament has thickened beyond normal dimensions. Measurements exceeding 4–5 mm in the lumbar region are considered hypertrophic; severe cases reach 7–8 mm or more. That extra tissue protrudes into the spinal canal and compresses the structures inside it.

What Causes Ligamentum Flavum Hypertrophy?

LFH follows a recognizable progression. Intervertebral discs lose height and hydration with age, transferring abnormal mechanical stress to posterior structures — including the facet joints and the ligamentum flavum. This is directly connected to lumbar spondylosis, the broader degenerative process that drives many of these changes together.

Chronic stress triggers fibrosis: elastic fibers inside the ligament are progressively replaced by collagen. The ligament becomes stiffer, less pliable, and prone to buckling inward during spinal extension — directly into the posterior canal. That buckling compresses the dural sac and exiting nerve roots, impairing blood flow and producing the pain, cramping, and weakness of neurogenic claudication.

What Are the Symptoms?

LFH produces a recognizable clinical syndrome with three core features:

  • Neurogenic claudication: Leg pain, cramping, numbness, or weakness that develops with walking or prolonged standing and is relieved by sitting or bending forward. This positional pattern is the clinical signature of stenosis caused by LFH.
  • Bilateral leg symptoms: Unlike disc herniation, LFH-driven central stenosis produces symptoms in both legs — reflecting compression of the entire dural sac.
  • Low back pain: Dull, aching discomfort that accompanies the leg symptoms but is typically secondary to them.

Coexisting conditions such as spondylolisthesis or facet joint arthritis compound the canal narrowing and accelerate disability.

How Is LFH Diagnosed?

Diagnosis combines clinical history, physical examination, and imaging.

MRI is the primary tool. T2-weighted sequences show the thickened ligament bulging into the posterior canal and grade severity by dural sac cross-sectional area reduction: mild (less than one-third), moderate (one-third to two-thirds), severe (greater than two-thirds).

Clinical examination confirms the positional pattern — worsening with extension and relief with flexion — alongside neurological findings such as reduced reflexes or lower-extremity weakness.

What Are the Non-Surgical Treatment Options?

For mild to moderate LFH, conservative care is the starting point: physical therapy, anti-inflammatory medications, and activity modification. An AAFP systematic review found epidural steroid injections not effective for chronic low back pain; their role in neurogenic claudication is limited for long-term relief.

When stenosis is substantially driven by underlying disc degeneration and annular tears, addressing disc pathology is a clinically relevant option. Biologic disc repair through intra-annular fibrin injection uses an FDA-approved fibrin sealant to address tears in the disc wall that contribute to segmental instability and the cascade that accelerates ligament hypertrophy. Among more than 7,000 tracked procedures with long-term follow-up, the success rate is 83%; individual outcomes vary. A clinical evaluation is the only way to know whether this approach fits a specific patient’s anatomy. You can review the full list of conditions where biologic disc repair applies for the broader candidacy picture.

When conservative care fails and neurological function is at risk, minimally invasive decompression or laminectomy become the surgical options. Back surgery carries roughly a 40% failure rate based on Failed Back Surgery Syndrome data; individual outcomes vary. Patients who have already undergone surgery and remain in pain can explore options for Failed Back Surgery Syndrome.

Expert Take

The Valor clinical team regularly evaluates patients whose imaging shows ligamentum flavum hypertrophy alongside disc tears. The two conditions often coexist — the disc loses structure, the spine becomes unstable, and the ligament compensates by thickening. For patients whose pain is meaningfully driven by disc pathology, addressing that component through intra-annular fibrin injection is part of a broader plan. A thorough evaluation is the only way to understand which structures are driving a specific patient’s symptoms.

Frequently Asked Questions

What causes ligamentum flavum hypertrophy?

LFH is caused by disc degeneration, segmental instability, and chronic mechanical stress on the posterior spinal ligaments. Elastic fibers inside the ligament are progressively replaced by collagen, making it thicker, stiffer, and prone to buckling into the spinal canal.

Can ligamentum flavum hypertrophy be treated without surgery?

Yes, for many patients. Conservative care — physical therapy, anti-inflammatory medications, and activity modification — is the standard first approach for mild to moderate LFH. For patients whose symptoms are driven in part by underlying disc pathology, addressing disc-level tears through biologic disc repair is an option a clinical evaluation can clarify. Surgery is reserved for severe canal compromise or progressive neurological deficits.

Does ligamentum flavum hypertrophy always require surgery?

Not always. Many patients with mild to moderate LFH manage symptoms effectively with conservative care. Surgery is generally reserved for severe canal compromise, progressive neurological deficits, or cases where conservative treatment has failed. A clinical evaluation is the only way to determine the right path.

How does LFH relate to disc degeneration?

Disc degeneration is one of the primary mechanical triggers for LFH. As discs lose height and structural integrity, abnormal load transfers to posterior spinal structures, accelerating ligament fibrosis and thickening. Treating the disc component reduces the mechanical stress driving ligament hypertrophy over time.

Sources

Next Steps

If your imaging shows ligamentum flavum hypertrophy — or if you’ve been told you have spinal stenosis and want to explore non-surgical paths — start with a clinical evaluation. The Valor team reviews existing imaging and determines whether the disc component, the ligament component, or both are driving your symptoms. See the full guide to non-surgical treatments for spinal stenosis to understand what the broader landscape of care looks like before your consultation.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.

Schedule appointment

Let’s Get Social